Impact of the EU Paediatric Medicine Regulation on new anti-cancer medicines for the treatment of children and adolescents
-д хадгалсан:
Үндсэн зохиолчид: | Gilles Vassal, Teresa de Rojas, Andrew D.J. Pearson |
---|---|
Формат: | Revisão |
Хэл сонгох: | англи |
Хэвлэсэн: |
2023
|
Онлайн хандалт: | https://doi.org/10.1016/s2352-4642(22)00344-3 https://www.sciencedirect.com/science/article/am/pii/S2352464222003443 |
Шошгууд: |
Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
Ижил төстэй зүйлс
-
The EU's new paediatric medicines legislation: serving children's needs?
-н: Permanand, Govin, зэрэг
Хэвлэсэн: (2007) -
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents()
-н: Pearson, Andrew. D.J., зэрэг
Хэвлэсэн: (2020) -
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents
-н: Andrew D.J. Pearson, зэрэг
Хэвлэсэн: (2020) -
Does the EU’s Paediatric Regulation work for new medicines for children in Denmark, Finland, Norway and Sweden? A cross-sectional study
-н: Lepola, Pirkko, зэрэг
Хэвлэсэн: (2020) -
Paediatric Strategy Forum for Medicinal Product Development in Diffuse Midline Gliomas in Children and Adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration
-н: Andrew D.J. Pearson, зэрэг
Хэвлэсэн: (2025)